Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 92 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8088931

    Small molecule inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  2. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  3. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  4. US 8071618

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  5. US 8071766

    HSP90 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  6. US 8071645

    Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

    The Regents of the University of Colorado · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  7. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  8. US 8067417

    Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  9. US 8067473

    Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  10. US 8067606

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  11. US 8063248

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  12. US 8063066

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  13. US 8063089

    Inhibitors of nucleophosmin (NPM) and methods for inducing apoptosis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  14. US 8058271

    Selective inhibitors of rock protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  15. US 8058295

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  16. US 8053434

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  17. US 8048909

    Proton pump inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  18. US 8044033

    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  19. US 8039661

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  20. US 8039623

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  21. US 8034832

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  22. US 8034821

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  23. US 8034812

    Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted
  24. US 8034768

    Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted